ArticleJournal of clinical microbiology2017
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- Mcr colistin resistance gene: a systematic review of current diagnostics and detection methods.MicrobiologyOpen · 2019Pooled it
- Mapping the resistance landscape: A large-scale study of polymyxin-resistant pathogens circulating in low-and middle-income countries.Research square · 2026Article
- Multidrug-Resistant Providencia rettgeri: An Emerging Pathogen in Farmed Siamese Crocodiles (Crocodylus siamensis) in Hainan, China.Transboundary and emerging diseases · 2026Article
- The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review.Antibiotics (Basel, Switzerland) · 2025Review
- Resistance is reality: findings from the first Ukrainian cumulative antibiogram.JAC-antimicrobial resistance · 2024Article
- Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections.Infection & chemotherapy · 2024Review
- Evaluation of an adapted method of relative growth to determine the susceptibility of Enterobacterales to polymyxin B by MALDI-TOF MS.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
- Virotyping and genetic antimicrobial susceptibility testing of porcine ETEC/STEC strains and associated plasmid types.Frontiers in microbiology · 2023Article
- Colistin Use in European Livestock: Veterinary Field Data on Trends and Perspectives for Further Reduction.Veterinary sciences · 2022Article
- Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities.Antibiotics (Basel, Switzerland) · 2022Article
- Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics.Journal of clinical microbiology · 2021Article
- RapidResa PolymyxinAntibiotics (Basel, Switzerland) · 2021Article
- Susceptibility Testing of Colistin forAntibiotics (Basel, Switzerland) · 2021Article
- Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-ResistantAntimicrobial agents and chemotherapy · 2020Article
- Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution.Journal of clinical microbiology · 2020Article
- Genomic Analysis of CarbapenemaseMicroorganisms · 2020Article
- Evaluation of resazurin-based assay for rapid detection of polymyxin-resistant gram-negative bacteria.BMC microbiology · 2020Article
- Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital.Heliyon · 2019Article
- Colistin Resistance in Enterobacterales Strains - A Current View.Polish journal of microbiology · 2019Review
- Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing inJournal of clinical microbiology · 2019Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optimizing and standardizing susceptibility testing for the polymyxins have become pressing issues, given the rise in multidrug-resistant Gram-negative bacilli. Recently, both the CLSI and EUCAST have recommended broth microdilution (BMD) (without polysorbate) as the reference method for polymyxin susceptibility testing. In this issue, K. L. Chew et al. (J Clin Microbiol 55:2609-2616, 2017, https://doi.org/10.1128/JCM.00268-17) compare the performances of three commercial BMD panels and the Etest to the reference, BMD, for polymyxin B and colistin, using 76
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.